Volver al artículo.

Referencias para el artículo

1. Sabelli HC. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. J Clin Psychiatry 1986;47:66–70.
2. Fischer E, Heller B, Nachon M, Spatz H. Therapy of depression by phenylalanine. Arzneimittelforschung 1975;25:132.
3. Heller B, Fischer E, Martin R. Therapeutic action of D-phenylalanine in Parkinson’s disease. Arzneimittelforschung 1976;26:577–9.
4. Budd K. Use of D-phenylalanine, an enkephalinase inhibitor, in the treatment of intractable pain. Adv Pain Res Ther 1983;5:305–8.
5. Anonymous. Phenylalanine fails to help chronic back pain patients. Fam Pract News 1987;17:37.
6. Burkhart CG, Burkhart CN. Phenylalanine with UVA for the treatment of vitiligo needs more testing for possible side effects. J Am Acad Dermatol 1999;40:1015 [letter].